Your browser doesn't support javascript.
loading
12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.
Luetkemeyer, Anne F; McDonald, Cheryl; Ramgopal, Moti; Noviello, Stephanie; Bhore, Rafia; Ackerman, Peter.
Affiliation
  • Luetkemeyer AF; University of California, San Francisco.
  • McDonald C; Tarrant County Infectious Disease Associates, Fort Worth, Texas.
  • Ramgopal M; Midway Immunology and Research Center, Fort Pierce, Florida.
  • Noviello S; Bristol-Myers Squibb, Lawrenceville.
  • Bhore R; Bristol-Myers Squibb, Hopewell, New Jersey.
  • Ackerman P; Bristol-Myers Squibb, Wallingford, Connecticut.
Clin Infect Dis ; 62(12): 1489-96, 2016 06 15.
Article in En | MEDLINE | ID: mdl-27025835
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / HIV Infections / Hepatitis C / Coinfection / Sofosbuvir / Imidazoles Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2016 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / HIV Infections / Hepatitis C / Coinfection / Sofosbuvir / Imidazoles Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2016 Type: Article